China Shineway Pharmaceutical Group Limited (C1S) — Free Cash Flow Generation Index
China Shineway Pharmaceutical Group Limited (C1S) has a Free Cash Flow Generation Index of 1.15x as of June 2023. Free cash flow of €185.26 Million represents 1% of operating cash flow (€160.69 Million). See C1S working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
China Shineway Pharmaceutical Group Limited Free Cash Flow Generation Index (2013–2025)
Historical FCF Generation Index trend for China Shineway Pharmaceutical Group Limited across 13 annual periods. Explore China Shineway Pharmaceutical Group Limi (C1S) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for China Shineway Pharmaceutical Group Limited (2013–2025)
Year-by-year Free Cash Flow Generation Index for China Shineway Pharmaceutical Group Limited. For the full company profile including market capitalisation, see C1S stock market capitalisation.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.83x | €974.13 Million | €1.17 Billion | €197.91 Million | ▼ -2.7% |
| 2024 | 0.85x | €823.02 Million | €963.13 Million | €140.11 Million | ▲ +1.1% |
| 2023 | 0.85x | €788.31 Million | €932.63 Million | €144.32 Million | ▼ -4.3% |
| 2022 | 0.88x | €980.21 Million | €1.11 Billion | €129.46 Million | ▲ +1.9% |
| 2021 | 0.87x | €609.52 Million | €703.15 Million | €93.63 Million | ▼ -3.3% |
| 2020 | 0.90x | €572.54 Million | €638.57 Million | €66.03 Million | ▲ +19.3% |
| 2019 | 0.75x | €276.59 Million | €368.00 Million | €88.40 Million | ▲ +1.9% |
| 2018 | 0.74x | €392.79 Million | €532.59 Million | €127.34 Million | ▼ -9.3% |
| 2017 | 0.81x | €398.82 Million | €490.65 Million | €91.83 Million | ▼ -29.0% |
| 2016 | 1.15x | €840.32 Million | €733.53 Million | €106.79 Million | ▲ +0.2% |
| 2015 | 1.14x | €851.26 Million | €744.71 Million | €106.56 Million | ▲ +0.7% |
| 2014 | 1.13x | €877.34 Million | €773.16 Million | €104.18 Million | ▼ -24.5% |
| 2013 | 1.50x | €781.77 Million | €519.89 Million | €261.89 Million | — |